Key result
Simple surface electromyography detected spontaneous activity compatible with neuromyotonia in 82% of recordings in patients directly after oxaliplatin infusion.
Why the study?
Oxaliplatin-induced neurotoxicity can be dose-limiting, and an accessible, non-invasive technique for early detection could help select patients for potential treatments.
Does simple surface electromyography (sEMG) detect acute oxaliplatin-induced neurotoxicity in patients with colorectal cancer?
Observational (n=14)
Does simple surface electromyography (sEMG) detect acute oxaliplatin-induced neurotoxicity in patients with colorectal cancer?
Simple surface EMG is a feasible, non-invasive screening tool that can objectively detect nerve hyperexcitability directly after oxaliplatin administration.
Answers are grounded in this paper and cite their sources.
sEMG may enable early oxaliplatin neurotoxicity detection; leaves open clinical utility pending validation studies.
OBJECTIVES: Oxaliplatin-induced neurotoxicity can be a dose-limiting side effect to effective chemotherapy. Acute hyperexcitability causes cold-evoked sensory and motor symptoms, which resemble neuromyotonia. An accessible and non-invasive technique for early detection could help select patients for potential treatments. We assessed the use of a simple surface electromyography (sEMG) in patients directly after oxaliplatin infusion. METHODS: In patients with colorectal cancer, acute neurotoxicity was evaluated by means of a physical examination, a questionnaire, and sEMG directly after the second and fourth cycle of oxaliplatin. Questionnaires were also assessed 1 day after infusion. RESULTS: 14 patients were measured after the second cycle and 8 patients were also measured after the fourth cycle of oxaliplatin. All patients reported to a variable degree oxaliplatin induced neurotoxicity symptoms: sensitivity to touching cold or swallowing cold items were reported as most severe. Clinical signs of hyperexcitability were observed in 55% of the measurements. Spontaneous activity compatible with neuromyotonia was observed in 82% of the sEMG recordings. CONCLUSIONS: Patient reported symptoms, physical examination and simple sEMG are complementary measurements to detect acute oxaliplatin induced neurotoxicity. After further validation, sEMG recording can be used as a simple objective screenings tool to detect nerve hyperexcitability directly after oxaliplatin administration.
No takes yet. Share an insight, caveat, or question.
Heuvel et al. (2019) conducted an observational in Colorectal cancer (n=14). Simple surface electromyography (sEMG) was evaluated on Spontaneous activity compatible with neuromyotonia on sEMG. Simple surface electromyography detected spontaneous activity compatible with neuromyotonia in 82% of recordings in patients directly after oxaliplatin infusion.
Synapse has enriched 10 related papers. Consider them for comparative context: